Skip to content

The Role of Electroacupuncture With Standard Therapy on Sperm Analysis and SOD Levels in Oligozoospermia.

The Role of Electroacupuncture With Standard Therapy on Sperm Analysis and SOD Levels in Oligozoospermia.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06088693
Enrollment
48
Registered
2023-10-18
Start date
2023-09-11
Completion date
2023-12-22
Last updated
2023-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oligoasthenoteratozoospermia, Oligoasthenozoospermia, Oligozoospermia

Brief summary

The goal of this clinical trial is to compare in Oligozoospermia Patient. The main questions it aims to answer are: 1. Electroacupuncture therapy and standard therapy can affect oligozoospermia. 2. Electroacupuncture therapy and standard therapy can affect semen and spermatozoa plasma SOD levels. Researchers will compare patient with standard therapy with patient with standard therapy with electroacupuncture.

Detailed description

1. Male subjects aged more than 25 years and less than 45 years. 2. Oligozoospermia according to the 2010 WHO criteria is mild (10-15 million spermatozoa/mL), moderate (5-10 million spermatozoa/mL) and severe (\<5 million spermatozoa/mL). 3. Willing to take part in research and sign informed consent.

Interventions

OTHERElectroacupuncture and Standard Therapy

Acupuncture Needle Insertion with Electroacupuncture machine.

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

The investigator blind the participant allocation

Eligibility

Sex/Gender
MALE
Age
25 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Male 25 to 45 years old. * Oligozoospermia according to the 2010 WHO criteria is mild (10-15 million spermatozoa/mL), moderate (5-10 million spermatozoa/mL) and severe (\<5 million spermatozoa/mL). * Willing to participate in research and sign informed consent.

Exclusion criteria

* Emergency case patient / bleeding disorders * Have a tumor, scar tissue or infected wound in the area where the acupuncture needle will be inserted. * Alcoholic * Using a pacemaker (heart pacemaker). * Azoospermia * Varicocele

Design outcomes

Primary

MeasureTime frameDescription
Sperm analysisBefore Treatment in day 1, After 30 days of treatment.Spermatozoa/mL
SOD SpermatozoaBefore Treatment in day 1, After 30 days of treatment.Superokside Dismutase in Spermatozoa
SOD Plasma SemenBefore Treatment in day 1, After 30 days of treatment.Superokside Dismutase in Plasma Semen

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026